News

Filter

Current filters:

GlaxoSmithKline

126 to 135 of 96123 results

US HHS contracts with Mapp Biopharmaceutical to develop Ebola drug

03-09-2014

The US Department of Health and Human Services has awarded a $25 million contract to Mapp Biopharmaceutical…

Anti-viralsBiotechnologyFinancialMapp BiopharmaceuticalResearchTropical diseasesUSAZMapp

Teva gets positive UK judgment in case against AstraZeneca

Teva gets positive UK judgment in case against AstraZeneca

03-09-2014

A positive judgment has been given by the UK High Court in support of Israeli generic drug giant Teva…

AstraZenecaDuoResp SpiromaxGenericsLegalPatentsRespiratory and PulmonarySymbicortTeva Pharmaceutical IndustriesUK

Richard Pasternak to replace Jean-Pierre Garnier as chairman of Cerenis

Richard Pasternak to replace Jean-Pierre Garnier as chairman of Cerenis

03-09-2014

French biotechnology company Cerenis has appointed Richard Pasternak as chairman of the board of directors.

Nabriva appoints Colin Broom as chief executive

Nabriva appoints Colin Broom as chief executive

03-09-2014

Austrian biotech company Nabriva Therapeutics has appointed Colin Broom as chief executive.

BoardroomNabriva Therapeutics

Luye Pharma to acquire majority stake in Beijing Jialin for $599 million

Luye Pharma to acquire majority stake in Beijing Jialin for $599 million

03-09-2014

Hong Kong-based Luye Pharma has entered into an agreement to purchase a 57.98% stake of Beijing Jialin…

Beijing Jialin PharmaceuticalCardio-vascularChinaLuye PharmaMergers & AcquisitionsPharmaceutical

Strong Ph IIb results with Dezima’s CETP inhibitor TA-8995 in dyslipidemia

Strong Ph IIb results with Dezima’s CETP inhibitor TA-8995 in dyslipidemia

03-09-2014

Privately-held Dutch biotech firm Dezima Pharma says it has received very positive results in its Phase…

BiotechnologyCardio-vascularDEZ-001Dezima PharmaMitsubishi TanabeResearchTA-8995

FDA accepts Actavis NDA for eluxadoline

FDA accepts Actavis NDA for eluxadoline

03-09-2014

Ireland-headquartered generic drug major Actavis says that the US Food and Drug Administration has accepted…

ActaviseluxadolineForest LaboratoriesFuriex PharmaceuticalsGastro-intestinalsPharmaceuticalRegulationUSA

FDA Breakthrough designation for ACADIA’s Nuplazid for Parkinson’s disease psychosis

FDA Breakthrough designation for ACADIA’s Nuplazid for Parkinson’s disease psychosis

03-09-2014

US biotech firm ACADIA Pharmaceuticals says that the US Food and Drug Administration has granted Breakthrough…

ACADIA PharmaceuticalsBiotechnologyNeurologicalNuplazidpimavanserinRegulationUSA

Bristol-Myers Squibb launches Daklinza in the UK for chronic hepatitis C

Bristol-Myers Squibb launches Daklinza in the UK for chronic hepatitis C

03-09-2014

US drug major Bristol-Myers Squibb has launched Daklinza (daclastavir) in the UK for chronic hepatitis…

AntiviralsBristol-Myers SquibbDaklinzaHepatitis CNephrology and HepatologyPharmaceuticalRegulationUK

126 to 135 of 96123 results

Back to top